Cheng Wang
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- RNA Research and Splicing
Papers in
- Cancer Research 141
- MicroRNA in disease regulation 84
- Cancer-related molecular mechanisms research 72
- Cancer, Hypoxia, and Metabolism 12
-
- Circular RNAs in diseases 54
- Extracellular vesicles in disease 32
- RNA modifications and cancer 29
Cheng Wang
369 papers receiving 11.9k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Cancer Research 5.2k
- Molecular Biology 7.0k
- Pathology and Forensic Medicine 717
- Immunology 738
- Oncology 939
Countries citing papers authored by Cheng Wang
This map shows the geographic impact of Cheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Wang more than expected).
Fields of papers citing papers by Cheng Wang
This network shows the impact of papers produced by Cheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Wang. The network helps show where Cheng Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 57 | |
| 12 | 2022 | 25 | |
| 13 | 2022 | 12 | |
| 14 | 2021 | 42 | |
| 15 | MicroRNA-21 Mediates a Positive Feedback on Angiotensin II-Induced Myofibroblast Transformation | 2020 | 1 |
| 16 | 2018 | 32 | |
| 17 | 2018 | 1 | |
| 18 | 2016 | 140 | |
| 19 | 2013 | 10 | |
| 20 | [Expressions of hTERT, p53, c-erbB-2 and Bcl-2 in colonic adenocarcinoma mouse models with liver metastases: effects of classical traditional Chinese medicine prescriptions for promoting circulation and removing blood stasis]. | 2004 | 5 |
About Cheng Wang
Cheng Wang is a scholar working on Cancer Research, Molecular Biology, Hepatology, Oncology and Epidemiology, having authored 411 papers that have together received 12.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (84 papers), Cancer-related molecular mechanisms research (72 papers), Circular RNAs in diseases (54 papers), Extracellular vesicles in disease (32 papers), RNA modifications and cancer (29 papers), Liver Disease Diagnosis and Treatment (21 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Autophagy in Disease and Therapy (11 papers). The work is most often cited by research in Cancer Research (5.2k citations), Molecular Biology (7.0k citations), Pathology and Forensic Medicine (717 citations), Immunology (738 citations) and Oncology (939 citations). Cheng Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Chen‐Yu Zhang, Ke Zen, Junjun Wang, Yiguo Yan, Xi Chen, Yajuan Liu, Xiaohua Yu, Yi Ba, Zhibin Hu and Lihong Gong. Their work appears in journals such as Scientific Reports, Biomedicine & Pharmacotherapy, PLoS ONE, Clinica Chimica Acta and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.